Skip to main content
Edwards Lifesciences Logo

ClearSight system:

The next generation of Nexfin technology

ClearSight system
ClearSight system
ClearSight system

In 2012, Edwards Lifesciences acquired BMEYE to advance the Nexfin technology into the ClearSight system, the next generation in noninvasive hemodynamic monitoring for continuous decision support.

Important safety information

CAUTION: Federal (United States) law restricts this device to sale by or on the order of a physician.
See Instructions For Use (IFU) / Directions For Use (DFU) for full prescribing information, including indications, contraindications, warnings, precautions and adverse events.